Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

Research output: Contribution to journalArticle

Abstract

The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.

Original languageEnglish
JournalJournal of Microbiology, Immunology and Infection
DOIs
Publication statusE-pub ahead of print - May 21 2019
Externally publishedYes

Fingerprint

Mycoplasma pneumoniae
Lung Diseases
Macrolides
Therapeutics

Cite this

@article{c5a70a401dc44baa83c65d0110251fb5,
title = "Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy",
abstract = "The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.",
author = "Dimitri Poddighe",
note = "Copyright {\circledC} 2019. Published by Elsevier B.V.",
year = "2019",
month = "5",
day = "21",
doi = "10.1016/j.jmii.2019.04.011",
language = "English",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "1684-1182",
publisher = "Elsevier",

}

TY - JOUR

T1 - Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

AU - Poddighe, Dimitri

N1 - Copyright © 2019. Published by Elsevier B.V.

PY - 2019/5/21

Y1 - 2019/5/21

N2 - The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.

AB - The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.

U2 - 10.1016/j.jmii.2019.04.011

DO - 10.1016/j.jmii.2019.04.011

M3 - Article

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 1684-1182

ER -